E2Fs regulate adipocyte differentiation

Developmental Cell

Volumn 3, Issue 1, 2002, Pages 39-49

  Fajas, Lluis ^a   Landsberg, Rebecca L ^b   Huss Garcia, Yolande ^a   Sardet, Claude ^c   Lees, Jacqueline A ^b   Auwerx, Johan ^a  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c INSTITUT DE GÉNÉTIQUE MOLÉCULAIRE DE MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRANSCRIPTION FACTOR E2F;

ADIPOCYTE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; FEMALE; GENE EXPRESSION REGULATION; GENE REPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN INDUCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STEM CELL;

ANIMALIA;

EID: 0036069979     PISSN: 15345807     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1534-5807(02)00190-9     Document Type: Article

References (51)

1. PPARγ induces cell cycle withdrawal: Inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A
2. Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interaction with C/EBPs
3. Opposing roles of pRB and p107 in adipocyte differentiation
4. Cell cycle-specific association of E2F with the p130 E1A-binding protein
5. The nuclear receptor, PPARγ, is aberrantly expressed in colonic cancers
6. The regulation of E2F by pRB-family proteins
7. Organization, promoter analysis and expression of the human PPARγ gene
8. Peroxisome proliferator-activated receptor-gamma: From adipogenesis to carcinogenesis
9. PPARγ3 mRNA: A distinct PPARγ mRNA subtype transcribed from an independent promoter
10. Transcriptional control of adipogenesis
11. Regulation of PPARγ expression by ADD-1/SREBP-1: Implications for adipocyte differentiation and metabolism
12. E2F4 and E2F5 play an essential role in pocket protein-mediated G1 control
13. Unusual proliferation arrest and transcriptional control properties of a newly discovered E2F family member, E2F-6
14. An established preadipose cell line and its differentiation in culture II. Factors affecting adipose conversion
15. Activation of peroxisome proliferator activated receptor γ bypasses the function of the retinoblastoma protein in adipocyte differentiation
16. The Rb/E2F pathway: Expanding roles and emerging paradigms
17. A eukaryotic transcriptional repressor with carboxypeptidase activity
18. Regulation of cell proliferation by the E2F transcription factors
19. The block of adipocyte differentiation by a C-terminally truncated, but not by full-length, simian virus 40 large tumor antigen is dependent on an intact retinoblastoma susceptibility protein family binding domain
20. E2F4 is essential for normal erythrocyte maturation and neonatal viability
21. E2f3 is critical for normal cellular proliferation
22. Global role for chromatin remodeling enzymes in mitotic gene expression
23. Cell cycle-regulated histone acetylation required for expression of the yeast HO gene
24. Nuclear localization of DP and E2F transcription factors by heterodimeric partners and retinoblastoma protein family members
25. Role of PPARgamma in regulating a cascade expression of cyclin-dependent kinase inhibitors, p18(INK4c) and p21(Waf1/Cip1), during adipogenesis
26. Terminal differentiation of human breast cancer through PPARγ
27. Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer
28. E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis
29. Production and analysis of ES-cell aggregation chimeras
30. Mitotic clonal expansion during preadipocyte differentiation: Calpain- mediated turnover of p27
31. E2F repression by C/EBPalpha is required for adipogenesis and granulopoiesis in vivo
32. Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with Oil red O
33. Analysis of cell cycle arrest in adipocyte differentiation
34. Loss of E2F4 activity leads to abnormal development of multiple cellular lineages
35. Regulation and expression of retinoblastoma proteins p107 and p130 during 3T3-L1 adipocyte differentiation
36. PPARgamma is required for the differentiation of adipose tissue in vivo and in vitro
37. Transcriptional regulation of adipogenesis
38. Inhibition of adipogenesis by Wnt signaling
39. Differential regulation of peroxisome proliferator activated receptor γ1 (PPARγ1) and PPARγ2 mRNA expression in early stages of adipogenesis
40. Peroxisome proliferator-activated receptor gamma as a novel target in cancer therapy: Binding and activation by an aromatic fatty acid with clinical antitumor activity
41. E2Fs and the retinoblastoma protein family
42. E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle
43. PPARα and PPARγ activators direct a tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene
44. Pref-1, a protein containing EGF-like repeats, inhibits adipocyte differentiation
45. Analysis of promoter binding by the E2F and pRB families in vivo: Distinct E2F proteins mediate activation and repression
46. CCAAT/enhancer-binding protein α (C/EBPα) inhibits cell proliferation through the p21 (WAF-1/CIP-1/SDI-1) protein
47. Function of GATA transcription factors in preadipocyte-adipocyte transition
48. mPPARγ2: Tissue-specific regulator of an adipocyte enhancer
49. Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
50. Sibling rivalry in the E2F family
51. E2F activity is regulated by cell cycle-dependent changes in subcellular localization